Parathyroid hormone and myocardial performance in dialysis patients
- PMID: 1882823
- DOI: 10.1016/s0272-6386(12)80090-4
Parathyroid hormone and myocardial performance in dialysis patients
Abstract
Whether parathyroid hormone (PTH) has a clinically important effect on myocardial performance is unclear. Previous investigations of cardiac function before and after parathyroidectomy have failed to control for ionized calcium, other biochemical parameters, or heart rate and cardiovascular loading conditions. We performed load- and rate-independent measurements of myocardial contractility in seven stable hemodialysis patients before and after surgical parathyroidectomy under identical conditions of blood ionized calcium (Ca2+), electrolytes, pH, PO2, and hematocrit. Mid-molecule PTH decreased from 44 +/- 8 to 2 +/- 1 ng/mL. Aortic systolic and diastolic pressures, left ventricular chamber dimensions, end systolic wall stress, left ventricular contractility at a common level of afterload, and contractile reserve evaluated with dobutamine were similar before and after parathyroidectomy. Thus, PTH appears not to have a direct effect on myocardial contractile state in dialysis patients.
Similar articles
-
Effect of intravenous calcitriol on cardiac systolic and diastolic function in patients on hemodialysis.Am J Nephrol. 1998;18(5):404-10. doi: 10.1159/000013384. Am J Nephrol. 1998. PMID: 9730564
-
Left ventricular contractility varies directly with blood ionized calcium.Ann Intern Med. 1988 Apr;108(4):524-9. doi: 10.7326/0003-4819-108-4-524. Ann Intern Med. 1988. PMID: 3248127 Clinical Trial.
-
[Left ventricular systolic and diastolic dysfunction in patients with chronic renal failure treated with hemodialysis].Pol Arch Med Wewn. 2003 Apr;109(4):365-73. Pol Arch Med Wewn. 2003. PMID: 12931488 Polish.
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
The cardiocyte as a target for parathyroid hormone in end-stage renal disease.J Assoc Acad Minor Phys. 1994;5(2):59-61. J Assoc Acad Minor Phys. 1994. PMID: 8032177 Review.
Cited by
-
Review article: Biomarkers of clinical outcomes in advanced chronic kidney disease.Nephrology (Carlton). 2009 Jun;14(4):408-15. doi: 10.1111/j.1440-1797.2009.01119.x. Nephrology (Carlton). 2009. PMID: 19563383 Free PMC article. Review.
-
The surgical management of renal hyperparathyroidism.Eur Arch Otorhinolaryngol. 2012 Jun;269(6):1565-76. doi: 10.1007/s00405-011-1833-2. Epub 2011 Nov 20. Eur Arch Otorhinolaryngol. 2012. PMID: 22101574 Review.
-
Bone and mineral disorders in pre-dialysis CKD.Int Urol Nephrol. 2008;40(2):427-40. doi: 10.1007/s11255-008-9346-7. Int Urol Nephrol. 2008. PMID: 18368510 Review.
-
Should We Consider the Cardiovascular System While Evaluating CKD-MBD?Toxins (Basel). 2020 Feb 25;12(3):140. doi: 10.3390/toxins12030140. Toxins (Basel). 2020. PMID: 32106499 Free PMC article. Review.
-
Hyperparathyroidism of Renal Disease.Perm J. 2016 Summer;20(3):15-127. doi: 10.7812/TPP/15-127. Epub 2016 Jul 22. Perm J. 2016. PMID: 27479950 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous